By: Benzinga
UPDATE: Citigroup Reiterates Neutral Rating, Lowers PT on C.R. Bard
In a report published Friday, Citigroup reiterated its Neutral rating on C.R. Bard (NYSE: BCR ), but lowered its price target from $103.00 to $99.00. Citigroup noted, “We rate shares of C.R. Bard Neutral. Bard re-emerged as a value play in the med tech space after its pending merger with
Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here